Disruption of the HIF-1 pathway in individuals with Ollier disease and Maffucci syndrome

被引:10
|
作者
Poll, Sarah R. [1 ]
Martin, Renan [1 ]
Wohler, Elizabeth [1 ]
Partan, Elizabeth S. [1 ]
Walek, Elizabeth [1 ]
Salman, Shaima [1 ]
Groepper, Daniel [2 ]
Kratz, Lisa [1 ]
Cernach, Mirlene [3 ]
Jesus-Garcia, Reynaldo [4 ]
Haldeman-Englert, Chad [5 ]
Choi, Yoon Jae [6 ]
Morris, Carol D. [7 ,8 ]
Cohen, Bernard [9 ]
Hoover-Fong, Julie [1 ]
Valle, David [1 ]
Semenza, Gregg L. [1 ]
Sobreira, Nara L. M. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, McKusick Nathans Dept Genet Med, Baltimore, MD 21218 USA
[2] Southern Illinois Univ, Sch Med, Dept Pediat, Springfield, IL USA
[3] Univ Metropolitana Santos, Santos, SP, Brazil
[4] Univ Fed Sao Paulo, Dept Orthoped Oncol, Sao Paulo, Brazil
[5] Mission Fullerton Genet Ctr, Asheville, NC USA
[6] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA
[7] Johns Hopkins Sch Med, Dept Orthoped Surg, Baltimore, MD USA
[8] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA
[9] Johns Hopkins Sch Med, Dept Dermatol, Baltimore, MD USA
来源
PLOS GENETICS | 2022年 / 18卷 / 12期
关键词
IDH2; MUTATIONS; BINDING SITES; HYPOXIA; HIF-1-ALPHA; HIF-2-ALPHA; REGULATOR; FRAMEWORK; GENES; TUMOR;
D O I
10.1371/journal.pgen.1010504
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Ollier disease (OD) and Maffucci Syndrome (MS) are rare disorders characterized by multiple enchondromas, commonly causing bone deformities, limb length discrepancies, and pathological fractures. MS is distinguished from OD by the development of vascular anomalies. Both disorders are cancer predisposition syndromes with malignancies developing in similar to 50% of the individuals with OD or MS. Somatic gain-of-function variants in IDH1 and IDH2 have been described in the enchondromas, vascular anomalies and chondrosarcomas of approximately 80% of the individuals with OD and MS. To date, however, no investigation of germline causative variants for these diseases has been comprehensively performed. To search for germline causative variants, we performed whole exome sequencing or whole genome sequencing of blood or saliva DNA in 94 unrelated probands (68 trios). We found that 7 had rare germline missense variants in HIF1A, 6 had rare germline missense variants in VHL, and 3 had IDH1 variants including 2 with mosaic IDH1-p.Arg132His variant. A burden analysis using 94 probands assigned as cases and 2,054 unrelated individuals presenting no OD- or MS-related features as controls, found that variants in HIF1A, VHL, and IDH1 were all significantly enriched in cases compared to controls. To further investigate the role of HIF-1 pathway in the pathogenesis of OD and MS, we performed RNA sequencing of fibroblasts from 4 probands with OD or MS at normoxia and at hypoxia. When cultured in hypoxic conditions, both proband and control cells showed altered expression of a subset of HIF-1 regulated genes. However, the set of differentially expressed genes in proband fibroblasts included a significantly reduced number of HIF-1 regulated genes compared to controls. Our findings suggest that germline or early post-zygotic variants identified in HIF1A, VHL, and IDH1 in probands with OD and MS underlie the development of the phenotypic abnormalities in a subset of individuals with OD and MS, but extensive functional studies are needed to further confirm it. Author summary Ollier disease (OD) and Maffucci Syndrome (MS) are rare disorders characterized by multiple enchondromas, commonly causing bone deformities, limb length discrepancies, and pathological fractures. MS is distinguished from OD by the development of vascular anomalies. Both disorders are cancer predisposition syndromes with malignancies developing in similar to 50% of the individuals with OD or MS. Somatic gain-of-function variants in IDH1 and IDH2 have been described in the enchondromas, vascular anomalies and chondrosarcomas of approximately 80% of the individuals with OD and MS. To date, however, no investigation of germline causative variants for these diseases has been comprehensively performed. To search for germline causative variants, we performed whole exome sequencing or whole genome sequencing of blood or saliva DNA in 94 unrelated probands. We found that rare germline missense variants in HIF1A, VHL, IDH1. Our burden analysis found that variants in HIF1A, VHL, and IDH1 were all significantly enriched in cases compared to controls. Our findings suggest that germline or early post-zygotic variants identified in HIF1A, VHL, and IDH1 in probands with OD and MS underlie the development of the phenotypic abnormalities in a subset of individuals with OD and MS, but extensive functional studies are needed to further confirm it.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] The association between intracranial tumours and multiple dyschondroplasia (Ollier’s disease or Maffucci’s syndrome): do children and adults differ?
    Adrianna Ranger
    Artur Szymczak
    Journal of Neuro-Oncology, 2009, 95 : 165 - 173
  • [42] The HIF-1-inducible Lysyl Oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell
    Reynaud, Caroline
    Pez, Floriane
    Dayan, Frederic
    Clezardin, Philippe
    Sommer, Pascal
    Pouyssegur, Jacques
    BULLETIN DU CANCER, 2011, 98 : S9 - S10
  • [43] Disruption of the HIF-1α/p300 interaction as a means of inhibiting angiogenesis
    Reece, Kelie M.
    Richardson, Emily D.
    Pisle, Stephen T.
    Holly, Alesia J.
    Campbell, Tessa J.
    Figg, William D.
    FASEB JOURNAL, 2012, 26
  • [44] Disruption of adipocyte HIF-1α improves atherosclerosis through the inhibition of ceramide generation
    Wang, Pengcheng
    Zeng, Guangyi
    Yan, Yu
    Zhang, Song-yang
    Dong, Yongqiang
    Zhang, Yangming
    Zhang, Xingzhong
    Liu, Huiying
    Zhang, Zhipeng
    Jiang, Changtao
    Pang, Yanli
    ACTA PHARMACEUTICA SINICA B, 2022, 12 (04) : 1899 - 1912
  • [45] Disruption of adipocyte HIF-1α improves atherosclerosis through the inhibition of ceramide generation
    Pengcheng Wang
    Guangyi Zeng
    Yu Yan
    Song-yang Zhang
    Yongqiang Dong
    Yangming Zhang
    Xingzhong Zhang
    Huiying Liu
    Zhipeng Zhang
    Changtao Jiang
    Yanli Pang
    ActaPharmaceuticaSinicaB, 2022, 12 (04) : 1899 - 1912
  • [46] UPREGULATION OF HIF-1 ALPHA ATTENUATES HYPOXIA/REOXYGENATION INJURY THROUGH HIF-1 ALPHA -INOS-PGC-1ALPHA PATHWAY
    Guo, Y.
    Feng, L.
    Yang, T.
    Shan, J.
    Sun, G.
    Li, S.
    Li, Y.
    TRANSPLANT INTERNATIONAL, 2012, 25 : 9 - 9
  • [47] HIF-1α increases the osteogenic capacity of ADSCs by coupling angiogenesis and osteogenesis via the HIF-1α/VEGF/AKT/mTOR signaling pathway
    Shuang Song
    Guanhua Zhang
    Xutao Chen
    Jian Zheng
    Xiangdong Liu
    Yiqing Wang
    Zijun Chen
    Yuxi Wang
    Yingliang Song
    Qin Zhou
    Journal of Nanobiotechnology, 21
  • [48] The HIF-1-Inducible Lysyl Oxidase Activates HIF-1 via the Akt Pathway in a Positive Regulation Loop and Synergizes with HIF-1 in Promoting Tumor Cell Growth
    Pez, Floriane
    Dayan, Frederic
    Durivault, Jerome
    Kaniewski, Bastien
    Aimond, Geraldine
    Le Provost, Gabrielle S.
    Deux, Blandine
    Clezardin, Philippe
    Sommer, Pascal
    Pouyssegur, Jacques
    Reynaud, Caroline
    CANCER RESEARCH, 2011, 71 (05) : 1647 - 1657
  • [49] Translational suppression of HIF-1α by miconazole through the mTOR signaling pathway
    Jee-Young Park
    Hui-Jung Jung
    Incheol Seo
    Bijay Kumar Jha
    Seong-Il Suh
    Min-Ho Suh
    Won-Ki Baek
    Cellular Oncology, 2014, 37 : 269 - 279
  • [50] Lanthanum hydroxide inhibits vascular calcification by regulating the HIF-1 pathway
    Wang, Shengnan
    Zhao, Lulu
    Liu, Hong
    Han, Ruilan
    Liu, Yang
    Gao, Jie
    Bu, Ren
    Li, Bing
    Sun, Lijun
    Hao, Jian
    Zhao, Jianrong
    Li, Gang
    CELL BIOLOGY INTERNATIONAL, 2022, 46 (08) : 1275 - 1287